Developer of biosimilar theraputics
H.R. 5376 - Build Back Better Act - Issues related to supporting the growth of biosimilars in America to provide competition and tools to lower the cost of prescription medications

Work to advance policies that support companies that fully manufacture products in the USA. 

S. 164 - Biosimilars Education Act of 2021 - A bill to raise awareness of the efficacy and promise of biosimilars in the American health care system. 

Issues and policies that incent companies to increase their US footprint and adopt Made in America business practices. 

Policies to help grow the biosimilars marketplace in the United States. 

Policies focused on improving cancer care through access to affordable treatments.
PHA - Pharmacy
136 - Centers For Medicare and Medicaid Services (CMS) 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
NATHANSON+HAUCK
601 13th Street NW, Suite 290 North, Washington, DC, 20005, US
MEGAN HAUCK MARSHALL MELANIE JAN NATHANSON